Zydus Lifesciences Ltd.

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its API manufacturing facility located at Dabhasa near Vadodara. This facility underwent an inspection from April 21 to April 25 2025 and has been classified as Voluntary Action Indicated (VAI). FDA confirmed the inspection as closed.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.